Literature DB >> 18528435

Colocalization of kindlin-1, kindlin-2, and migfilin at keratinocyte focal adhesion and relevance to the pathophysiology of Kindler syndrome.

J E Lai-Cheong1, S Ussar, K Arita, I R Hart, J A McGrath.   

Abstract

Kindler syndrome (KS) results from pathogenic loss-of-function mutations in the KIND1 gene, which encodes kindlin-1, a focal adhesion and actin cytoskeleton-related protein. How and why abnormalities in kindlin-1 disrupt keratinocyte cell biology in KS, however, is not yet known. In this study, we identified two previously unreported binding proteins of kindlin-1: kindlin-2 and migfilin. Co-immunoprecipitation and confocal microscopy studies show that these three proteins bind to each other and colocalize at focal adhesion in HaCaT cells and normal human keratinocytes. Moreover, loss-of-function mutations in KIND1 result in marked variability in kindlin-1 immunolabeling in KS skin, which is mirrored by similar changes in kindlin-2 and migfilin immunoreactivity. Kindlin-1, however, may function independently of kindlin-2 and migfilin, as loss of kindlin-1 expression in HaCaT keratinocytes by RNA interference and in KS keratinocytes does not affect KIND2 or FBLIM1 (migfilin) gene expression or kindlin-2 and migfilin protein localization. In addition to identifying protein-binding partners for kindlin-1, this study also highlights that KIND1 gene expression and kindlin-1 protein labeling are not always reduced in KS, findings that are relevant to the accurate laboratory diagnosis of this genodermatosis by skin immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528435      PMCID: PMC2628768          DOI: 10.1038/jid.2008.58

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  22 in total

1.  Neonatal diagnosis of Kindler syndrome.

Authors:  Hiva Fassihi; Vesarat Wessagowit; Catherine Jones; Patricia Dopping-Hepenstal; Jackie Denyer; Jemima E Mellerio; Sheila Clark; John A McGrath
Journal:  J Dermatol Sci       Date:  2005-09       Impact factor: 4.563

2.  Novel and recurrent KIND1 mutations in two patients with Kindler syndrome and severe mucosal involvement.

Authors:  A Tülin Mansur; Nursel H Elcioglu; Ikbal E Aydingöz; A Deniz Akkaya; Zehra Asiran Serdar; Corinna Herz; Leena Bruckner-Tuderman; Cristina Has
Journal:  Acta Derm Venereol       Date:  2007       Impact factor: 4.437

3.  Five new homozygous mutations in the KIND1 gene in Kindler syndrome.

Authors:  Joey E Lai-Cheong; Lu Liu; Gomathy Sethuraman; Rajesh Kumar; Vinod K Sharma; Siva R Reddy; Anders Vahlquist; Sandra Pather; Ken Arita; Vesarat Wessagowit; John A McGrath
Journal:  J Invest Dermatol       Date:  2007-04-26       Impact factor: 8.551

4.  The Kindlins: subcellular localization and expression during murine development.

Authors:  Siegfried Ussar; Hao-Ven Wang; Stefan Linder; Reinhard Fässler; Markus Moser
Journal:  Exp Cell Res       Date:  2006-06-29       Impact factor: 3.905

5.  Kindlin-1 is a phosphoprotein involved in regulation of polarity, proliferation, and motility of epidermal keratinocytes.

Authors:  Corinna Herz; Monique Aumailley; Carsten Schulte; Ursula Schlötzer-Schrehardt; Leena Bruckner-Tuderman; Cristina Has
Journal:  J Biol Chem       Date:  2006-10-01       Impact factor: 5.157

6.  An Indian child with Kindler syndrome resulting from a new homozygous nonsense mutation (C468X) in the KIND1 gene.

Authors:  G Sethuraman; H Fassihi; G H S Ashton; A Bansal; M Kabra; V K Sharma; J A McGrath
Journal:  Clin Exp Dermatol       Date:  2005-05       Impact factor: 3.470

7.  Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome.

Authors:  Florence Jobard; Bakar Bouadjar; Frédéric Caux; Smail Hadj-Rabia; Christina Has; Fumi Matsuda; Jean Weissenbach; Mark Lathrop; Jean-François Prud'homme; Judith Fischer
Journal:  Hum Mol Genet       Date:  2003-04-15       Impact factor: 6.150

8.  Kindler syndrome: a new mutation and new diagnostic possibilities.

Authors:  Joanna M Burch; Hiva Fassihi; Catherine A Jones; Sarah C Mengshol; James E Fitzpatrick; John A McGrath
Journal:  Arch Dermatol       Date:  2006-05

9.  Migfilin interacts with vasodilator-stimulated phosphoprotein (VASP) and regulates VASP localization to cell-matrix adhesions and migration.

Authors:  Yongjun Zhang; Yizeng Tu; Vasiliki Gkretsi; Chuanyue Wu
Journal:  J Biol Chem       Date:  2006-03-10       Impact factor: 5.157

10.  Recurrent KIND1 (C20orf42) gene mutation, c.676insC, in a Brazilian pedigree with Kindler syndrome.

Authors:  B C F Martignago; J E Lai-Cheong; L Liu; J A McGrath; T F Cestari
Journal:  Br J Dermatol       Date:  2007-10-04       Impact factor: 9.302

View more
  32 in total

Review 1.  Kindlins: essential regulators of integrin signalling and cell-matrix adhesion.

Authors:  Hannu Larjava; Edward F Plow; Chuanyue Wu
Journal:  EMBO Rep       Date:  2008-11-07       Impact factor: 8.807

Review 2.  Focal adhesion complex proteins in epidermis and squamous cell carcinoma.

Authors:  Elizabeth K Duperret; Todd W Ridky
Journal:  Cell Cycle       Date:  2013-09-12       Impact factor: 4.534

3.  Localization and potential function of kindlin-1 in periodontal tissues.

Authors:  Giorgio Petricca; Mari Leppilampi; Guoqiao Jiang; Gethin R Owen; Colin Wiebe; Yizeng Tu; Leeni Koivisto; Lari Häkkinen; Chuanyue Wu; Hannu Larjava
Journal:  Eur J Oral Sci       Date:  2009-10       Impact factor: 2.612

Review 4.  Kindlins in FERM adhesion.

Authors:  Nikolay L Malinin; Edward F Plow; Tatiana V Byzova
Journal:  Blood       Date:  2010-03-12       Impact factor: 22.113

Review 5.  Immunopathologies linked to integrin signalling.

Authors:  Hongyan Wang; Daina Lim; Christopher E Rudd
Journal:  Semin Immunopathol       Date:  2010-03-10       Impact factor: 9.623

Review 6.  Epithelial integrins with special reference to oral epithelia.

Authors:  H Larjava; L Koivisto; L Häkkinen; J Heino
Journal:  J Dent Res       Date:  2011-03-25       Impact factor: 6.116

7.  A Deep-Intronic FERMT1 Mutation Causes Kindler Syndrome: An Explanation for Genetically Unsolved Cases.

Authors:  Nadja Chmel; Sorina Danescu; Amelie Gruler; Dimitra Kiritsi; Leena Bruckner-Tuderman; Alexander Kreuter; Jürgen Kohlhase; Cristina Has
Journal:  J Invest Dermatol       Date:  2015-06-17       Impact factor: 8.551

8.  The integrin co-activator Kindlin-3 is expressed and functional in a non-hematopoietic cell, the endothelial cell.

Authors:  Katarzyna Bialkowska; Yan-Qing Ma; Kamila Bledzka; Khalid Sossey-Alaoui; Lahoucine Izem; Xiaoxia Zhang; Nikolay Malinin; Jun Qin; Tatiana Byzova; Edward F Plow
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

9.  Kindlin-1 Is required for RhoGTPase-mediated lamellipodia formation in keratinocytes.

Authors:  Cristina Has; Corinna Herz; Elena Zimina; Hai-Yan Qu; Yinghong He; Zhi-Gang Zhang; Ting-Ting Wen; Yannick Gache; Monique Aumailley; Leena Bruckner-Tuderman
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

10.  Loss-of-function FERMT1 mutations in kindler syndrome implicate a role for fermitin family homolog-1 in integrin activation.

Authors:  Joey E Lai-Cheong; Maddy Parsons; Akio Tanaka; Siegfried Ussar; Andrew P South; Sethuraman Gomathy; John B Mee; Jean-Baptiste Barbaroux; Tanasit Techanukul; Noor Almaani; Suzanne E Clements; Ian R Hart; John A McGrath
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.